TY  - GEN 
AU  - Sorlozano Puerto, Antonio
AU  - Carrasco, Cristina
AU  - Cabeza, José
AU  - Villegas Martínez, Enrique
AU  - Gutiérrez Fernández, José
PY  - 2009
UR  - https://hdl.handle.net/10481/90659
AB  - Antibiotics currently under study by the Food and Drugs Administration include: faropenem (for treatment of sinusitis, bronchitis, and community-acquired pneumonia), dalbavancin (for catheter infections), telavancin (for treatment of nosocomial...
LA  - eng
PB  - Bentham Science Publishers
KW  - Faropenem
KW  - Dalbavancin
KW  - Telavancin
KW  - Oritavancin
KW  - Ceftobiprole
KW  - Iclaprim
TI  - Antimicrobial development in the era of emerging resistance
DO  - 10.2174/138955709788681564
ER  -